Table 2.

The highest virus inhibition rates of drugs in three drug-adding modes (%).

Drug	Drug-adding method	Concentration (μg/mL)
		31.3	15.6	7.8	3.9
EF	1	174.7	162.4	157.5	113.4
	2	186.2	204.3	197.4	99.1
	3	73.3	87.9	70.7	30.9
BSRF	1	103.7	102.5	116.0	111.1
	2	125.9	154.3	139.7	134.5
	3	126.3	96.5	27.8	19.7
WDFF	1	73.7	46.2	53.7	-18.8
	2	58.3	95.6	81.7	61.7
	3	113.6	82.3	67.2	49.0
SF	1	68.2	75.3	67.1	73.5
	2	34.6	54.3	82.4	6.5
	3	45.6	74.8	55.2	51.9
EF-SF	1	46.2	-44.1	-32.4	-30.3
	2	91.7	88.2	97.2	64.6
	3	96.1	81.5	54.5	-10.1
EF-WDFF	1	64.9	1.4	3.5	-18.6
	2	161.1	163.9	123.6	101.4
	3	82.0	121.9	68.5	-0.6
WDFF-BSRF	1	26.9	24.8	-39.3	-34.5
	2	127.8	122.9	98.6	72.9
	3	97.2	117.9	96.1	55.0
EF-BSRF	1	96.0	119.3	137.3	-8.0
	2	177.7	246.6	249.5	215.5
	3	164.1	138.9	140.5	44.3
EF-WDFF-SF	1	22.5	143.8	56.3	108.8
	2	33.3	63.9	238.9	219.4
	3	13.6	48.0	58.1	63.6
WDFF-BSRF-SF	1	27.5	66.3	131.3	6.3
	2	138.5	247.9	209.4	177.8
	3	50.5	55.6	48.5	51.5
EF-BSRF-SF	1	51.7	33.1	38.6	29.0
	2	43.8	102.1	101.4	81.3
	3	23.6	33.7	-6.2	97.8
EF-WDFF-BSRF	1	82.7	76.0	82.7	55.3
	2	113.6	228.2	207.8	184.5
	3	86.3	155.7	106.9	80.2
EF-SF-WDFF-BSRF	1	150.0	111.3	17.3	14.7
	2	159.2	275.8	241.7	229.1
	3	140.5	127.5	130.5	83.2

Note: 1, 2, 3 means respectively pre-adding drug, post-adding drug and simultaneous-adding drug and virus.